| Antibiotics |
1 |
1 |
| Otolaryngology |
0 |
1 |
| Eosinophilia |
0 |
0.51 |
| Foot Pain |
0 |
0.38 |
| Fever |
0 |
0.37 |
| Pain Management |
0 |
0.37 |
| Pedal |
0 |
0.33 |
| Overuse Injury |
0 |
0.3 |
| Digital of Foot |
0 |
0.28 |
| Pneumonia |
0 |
0.28 |
| Type 2 Diabetes Mellitus |
0 |
0.28 |
| Peripheral Neuropathy |
0 |
0.26 |
| Complete Blood Count |
0 |
0.24 |
| Dyspnea |
0 |
0.23 |
| Cough |
0 |
0.19 |
| Eosinophils |
0 |
0.19 |
| Myalgia |
0 |
0.19 |
| Neuropathy |
0 |
0.19 |
| Osteomyelitis |
0 |
0.19 |
| Pain |
0 |
0.19 |
| Steroids |
0 |
0.19 |
| Thorax |
0 |
0.19 |
| Chest X-ray |
0 |
0.16 |
| Tuberculosis |
0 |
0.16 |
| Diabetes Mellitus |
0 |
0.14 |
| Electronic Health Record (EHR) |
0 |
0.13 |
| MRSA |
0 |
0.13 |
| Erectile Dysfunction |
0 |
0.11 |
| Patient Safety |
0 |
0.11 |
| Skeletal Myoblasts |
0 |
0.11 |
| Wound Management |
0 |
0.11 |
| Antimicrobial Stewardship |
0 |
0.1 |
| Blood |
0 |
0.09 |
| Bronchoalveolar Lavage |
0 |
0.09 |
| Bronchoscopy |
0 |
0.09 |
| CT Scan |
0 |
0.09 |
| Drug Reaction |
0 |
0.09 |
| Eosinophilic Pneumonia |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Liver |
0 |
0.09 |
| Microbicides |
0 |
0.09 |
| Muscle |
0 |
0.09 |
| Adverse Effects |
0 |
0.05 |
| Bacterial Pneumonia |
0 |
0.05 |
| COVID-19 |
0 |
0.05 |
| Dermatitis |
0 |
0.05 |
| Electronic Medical Record |
0 |
0.05 |
| Food and Drug Administration (FDA) |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Hepatitis |
0 |
0.05 |
| Hepatitis A |
0 |
0.05 |
| Injury |
0 |
0.05 |
| Leukocytosis |
0 |
0.05 |
| Lung |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Respiratory Tract Infections |
0 |
0.05 |
| Skeletal |
0 |
0.05 |
| Skin Rash |
0 |
0.05 |
| Staphylococcal Infection |
0 |
0.05 |
| Staphylococcus Aureus Infection |
0 |
0.05 |
| Travel Medicine |
0 |
0.05 |
| Wound |
0 |
0.05 |